UPMCPittsburgh, Pennsylvania, United States
I do not have any relevant financial / non-financial relationships with any proprietary interests.
1114 - Exploring bactericidal activity and emergence of resistance for carbapenem-resistant Enterobacterales (CRE) with and without Klebsiella pneumoniae carbapenemase (KPC) treated with optimized meropenem (MEM) and meropenem-vaborbactam (MEV) exposures
Friday, October 13, 202311:30 AM – 11:43 AM US ET